Stella W. King
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stella W. King.
Journal of Medicinal Chemistry | 1985
Joel R. Huff; Stella W. King; Walfred S. Saari; James P. Springer; Gregory E. Martin; Michael Williams
A number of 1-arylpiperazines have been characterized as direct-acting serotonin agonists. Conformational parameters of this class that may affect receptor recognition and binding have been examined through the analysis of X-ray data and synthesis of rigid analogues. Radioligand binding studies indicate that 2,3,4,4a,5,6-hexahydro-9-(trifluoromethyl)-1H-pyrazino[1,2-a]quinoline, an arylpiperazine that mimics the X-ray conformation of the serotonin agonist 1-(6-chloropyrazin-2-yl)piperazine, exhibits high affinity for serotonin receptors, suggesting that the two rings of 1-arylpiperazines are relatively coplanar in the bioactive conformation.
Journal of Medicinal Chemistry | 1992
Jason Matthew Elliott; Harold G. Selnick; David A. Claremon; John J. Baldwin; Susan A. Buhrow; John W. Butcher; Charles N. Habecker; Stella W. King; Joseph J. Lynch
Journal of Organic Chemistry | 1985
Cavid C. Remy; Stella W. King; David W. Cochran; James P. Springer; Jordan Hirshfield
Journal of Organic Chemistry | 1985
Steven D. Young; John J. Baldwin; David W. Cochran; Stella W. King; David C. Remy; James P. Springer
Archive | 1980
Joel R. Huff; Stella W. King; Walfred S. Saari
Heterocycles | 1987
Steven D. Young; Stella W. King; David C. Remy
Journal of Organic Chemistry | 1971
Walfred S. Saari; Andrew W. Raab; Stella W. King
Journal of Organic Chemistry | 1982
Joel R. Huff; Stella W. King; Walfred S. Saari
Archive | 1993
David C. Remy; John J. Baldwin; David A. Claremon; Stella W. King
Archive | 1988
John J. Baldwin; David A. Claremon; Gerald S. Ponticello; Stella W. King; David C. Remy